AI Revolution: Bristol Myers & Microsoft Unite
- Sarah Ruivivar

- Jan 27
- 2 min read

Bristol Myers Squibb is teaming up with Microsoft to revolutionise lung cancer detection using cutting-edge AI technology.
Recently, the pharmaceutical giant announced its partnership with Microsoft to utilise the tech titan's AI-enabled radiology platform, aiming to accelerate early lung cancer detection.
The collaboration will leverage U.S. FDA-cleared radiology AI algorithms through Microsoft's Precision Imaging Network. This advanced system analyses X-ray and CT images to detect lung disease and is already in use across hospitals in the United States. The goal? To help clinicians identify elusive lung nodules and catch the disease in its early stages.
A significant focus of this partnership is to enhance access to early detection in medically underserved communities, including rural hospitals and community clinics across the U.S. By marrying Microsoft's scalable radiology solutions with Bristol Myers' oncology expertise, the duo aims to create an AI-powered workflow that swiftly and accurately identifies patients with non-small cell lung cancer, guiding them towards optimal care and precision therapies.
Want to hear more? Join Mal & Matt on the Property AI Report Podcast each week!
Access from your preferred podcast provider by clicking here
Alexandra Goncalves, Vice President and Head of Digital Health at Bristol Myers Squibb, expressed enthusiasm for this unique AI-enabled approach, emphasising its potential to transform patient outcomes.
This collaboration is part of a broader trend where pharmaceutical companies are increasingly embracing AI to boost research and development. For instance, AstraZeneca recently acquired Modella AI to enhance oncology drug research.
With AI's potential to streamline processes and improve efficiency, the future of healthcare looks promising—and Bristol Myers and Microsoft are at the forefront of this exciting journey.
Want to hear more? Join Mal & Matt on the Property AI Report Podcast each week!
Access from your preferred podcast provider by clicking here

Made with TRUST_AI - see the Charter: https://www.modelprop.co.uk/trust-ai




Comments